Sports luminaries including Mike Tyson will be among the world-leading speakers headlining the largest psychedelic medicine business conference next month.
From 8-9 November, Miami, Florida will play host to Wonderland, the largest ever business gathering in the psychedelic medicine sector.
The event will welcome companies and speakers from across the globe, among them those at the cutting edge of a revolution in the treatment of mental health, addiction and pain challenges.
The Wonderland conference comes as almost 1,000 new psychedelic clinics have opened in the US, prompting an explosion of investor interest across Florida.
For more than a billion patients worldwide with conditions including mental health afflictions, traumatic brain injury, opioid addiction, strokes, dementia and menopause, psychedelic medicine offers new hope, with the FDA awarding breakthrough therapy status to groups working with MDMA and Psilocybin.
World-leading experts
Joined by scientists from Johns Hopkins, UCSF, Imperial College London, and leading financiers, innovators and CEOs, the conference will showcase the massive scientific advances, explosive growth and inspiring patient stories which have made this the fastest growing sector in medicine.
Headline speakers include former boxer Mike Tyson who now acts as an advisor to Wesana Health, basketball star Lamar Odom and USA Rugby Women’s Premier League (WPL) player, Anna Symonds, alongside Mindcure CEO Kelsey Ramsden and Lynn Marie Morski, president of the Psychedelic Medicine Association, the Adrienne Arsht Center.
Keynote speakers include; Robin Carhart-Harris and Ralph Metzner, Distinguished Professor of Neurology & Psychiatry, Director Psychedelics Division, Neuroscape, UCSF, Professor David Nutt, chief research officer, and Dr Ben Sessa, chief medical officer from Awakn Life Sciences, Dr Matthew W Johnson, Ph.D., Professor of Psychiatry and Behavioural Sciences at Johns Hopkins and Rick Doblin, Ph.D. in conversation with Patrick Moher.
”I believe if I’d been introduced to the benefit of psychedelics for therapeutic use early in my professional career, I may not have encountered as much anxiety or depression,” Tyson commented.
“I’m excited to be speaking among the most talented researchers, scientists and minds such as Dr. Robin Carhart-Harris, Prof. David Nutt, Dr. Ben Sessa, Dr Matthew W. Johnson, Ph.D, Rick Doblin, Ph.D. at Wonderland: Miami.
“Events like Wonderland: Miami are immensely important in helping improve mental health by showing people how life-altering experiences with psychedelic medicines can be.”
Heightened investor focus
Given a number of factors including the growth potential of the psychedelic medicine market, the NASDAQ listing of a number of psychedelic medicine companies as well as heightened investor focus received from Peter Thiel and many key Miami-based investors, Wonderland has attracted a top cohort of financiers including one of the leading franchises in the Psychedelics sector, H.C. Wainwright & Co., LLC., as its Official Banking Sponsor.
Among groundbreaking psychedelic medicine companies supporting Wonderland: Miami are Numinus, Mindset Pharma, Wesana Health, The Conscious Fund, Nushama, Braxia Scientific, Awakn Life Sciences, Levitee Labs, Negev Capital, Ambria Capital, MINDCURE, KGK Science, Psychedelic Water, Zuber Lawler, IMIO Life Ltd, Cybin, MNP LLP, Iter Investments, Ibogacine, Tryp Therapeutics, Psychedelic Invest, Entheo Digital, and Maya Health.
Patrick Moher, CEO, Microdose Psychedelics Insights, commented: ”Microdose is thrilled to be bringing together the best and brightest in the psychedelic industry for our first Wonderland experience. Appetites to meet and greet in person post-lockdowns are at an all time high, and we look forward to connecting a new generation of thought leaders in Miami.”
Wonderland: Miami is running November 8-9, 2021 in Miami, Florida at the Adrienne Arsht Center for the Performing Arts of Miami-Dade County.
Find out more here.
